01 — At a Glance
The Cement Clinic Patient Who Finally Got a Good Doctor
- 52-Week High / Low₹490 / ₹253
- CMP (13 Mar 2026)₹362
- Q3 FY26 Revenue₹1,114.26 Cr
- Q3 FY26 PAT₹5.74 Cr
- Q3 EPS-₹0.09
- Book Value (Sep 2025)₹325
- Price to Book1.10x
- Debt (Sep 2025)₹1,340 Cr
- Debt / Equity0.13x
- Interest Coverage0.27x
The Plot Twist: India Cements traded as a distressed asset earning negative returns on capital (ROE -8.83%, ROCE -5.49%). UltraTech acquired 75% control anyway. CARE upgraded from BB+ to AAA. Q3 returned to profitability at ₹5.74 Cr PAT. The stock is up 34% in a year. Either this is a masterclass in turnaround investing, or the market is pricing in a future that hasn’t happened yet. Both are possible.
02 — Introduction
When Your Cement Company Becomes a Redemption Arc
India Cements: founded in 1946 by two guys named Sankaralinga Iyer and T.S. Narayanaswami. For 75 years, it thrived. Built plants. Made cement. Sponsored an IPL team (Chennai Super Kings, in case you thought this company was boring). Then somewhere around 2018-2019, things got weird. Negative returns on capital. Declining market share. Mountains of debt. Leadership that seemed to be playing financial Jenga with other people’s money.
By FY24, the company reported a PAT of -₹227 crore. By FY25, it shrunk to -₹144 crore. The stock was basically a value trap wrapped in a bankruptcy sandwich. Then UltraTech Cement — India’s largest cement manufacturer — looked at this wreck and said, “Mine.”
In June 2024, UltraTech bought 22.77% from the open market. In July 2024, they bought another 32.72% from promoters at ₹390/share. Then came the open offer. And now, in March 2026, UltraTech owns 75%. CARE Ratings upgraded the company from BB+ to AAA. And somehow — just somehow — Q3 FY26 shows the company returned to profitability. A company that was hemorrhaging cash is now making money again. So what changed?
The UltraTech Effect: “Brand conversion… reached 69% in December ’25” (Kesoram). For India Cements, management says “crossed 58% at end-Dec ’25.” The thesis: slap UltraTech’s Coromandel brand on every cement bag, and suddenly the freight costs drop, realization improves, and the EBITDA per ton rises. Simple. Genius. Morbidly effective.
03 — Business Model: WTF Do They Actually Own?
14.45 MTPA of Regret (And Some Actual Value)
India Cements operates 10 cement manufacturing units (including split grinding units) across 5 states: Tamil Nadu, Andhra Pradesh, Telangana, Rajasthan, and Maharashtra. Total installed capacity: 14.45 MTPA. As of Q1 FY26, they sold 9 million tonnes annually and operated at 62% utilization — a euphemism for “lots of empty space.”
They have limestone reserves (good), captive power plants (redundant — cheaper to buy from grid now), and integrated shipping and coal mining operations that generate losses like clockwork. The brands — Sankar, Coromandel, Raasi — still carry weight in South India, especially Tamil Nadu. But legacy cost structures made every tone unprofitable. And then UltraTech arrived.
The strategy: absorb these plants into UltraTech’s operational playbook. Cut costs. Convert brands. Rationalize freight. Improve mix. Unlock synergies. On paper: ₹1,500 crore capex announced by UltraTech to fix operational inefficiencies. On reality: they’re spending that because the alternative was letting this elephant sit idle.
Installed Capacity14.45 MTPASouth India: 12.95 MTPA
FY25 Sales Volume8.98 MTDown from 9.42 MT (FY24)
FY25 Utilization62%Ouch.
Premium Share36%Of sales mix
The Brutal Truth: Before acquisition, India Cements was like owning a factory that needed constant life support. Negative ROCE means that every rupee of capital employed was destroying value. The books only balanced because of “Other Income” (asset sales, land disposal, pension benefits). It was bankruptcy theater.
💬 Do you believe a turnaround works when the parent company owns 75% and is spending ₹1,500 crore fixing your plants? Or is this just delayed restructuring?
04 — Financials Overview: The Resurrection Numbers
Q3 FY26: From Negative to… Less Negative
Continue reading with a premium membership.
